In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant Staphylococcus aureus Isolated from Bloodstream Infection Patients
Shuai Xia,Liyan Ma,Guoxing Wang,Jie Yang,Meiying Zhang,Xuechen Wang,Jianrong Su,Miaorong Xie
DOI: https://doi.org/10.2147/IDR.S357077
2022-04-20
Infection and Drug Resistance
Abstract:Shuai Xia, 1, &ast Liyan Ma, 2, &ast Guoxing Wang, 1 Jie Yang, 1 Meiying Zhang, 3 Xuechen Wang, 1 Jianrong Su, 2 Miaorong Xie 1 1 Department of Emergency and Critical Care Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China; 2 Department of Clinical Laboratory, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China; 3 Department of Emergency Center, Peking University First Hospital, Peking University, Beijing, 100050, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianrong Su, Department of Clinical Laboratory, Beijing Friendship Hospital, Capital Medical University, No. 95, Yong'an Road, Xicheng District, Beijing, 100050, People's Republic of China, Email Miaorong Xie, Department of Emergency and Critical Care Center, Beijing Friendship Hospital, Capital Medical University, No. 95, Yong'an Road, Xicheng District, Beijing, 100050, People's Republic of China, Email Purpose: To investigate the antimicrobial activity of berberine and the mechanism by which it combats methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bloodstream infections. Methods: Fifteen clinical MRSA isolates were collected, and their Multi-locus Sequence Types (MLST) were examined. The minimum inhibitory concentration (MIC) and combined antibacterial activity of berberine alone, and when combined with clindamycin and rifampicin separately, were determined. Additionally, two MRSA strains (ST239 and ST5) were selected to perform the time-killing assay and biofilm formation test. Cell wall alterations and cell membrane integrity were measured by confocal laser scanning microscopy (CLSM) and electron microscopy to assess the influence on cell morphology. Results: Our data showed berberine was effective against MRSA at MIC values varying from 256 to 64 mg&astL − 1 for different MLST types. Berberine alone, and when combined with clindamycin and rifampicin separately, displayed excellent antibacterial activity which reduced the bacterial counts by 2lgCFU&astmL within 24h and significantly weakened biofilm formation compared with control strain. Additionally, bacterial cytological profiling indicates that berberine destroyed the structure of the cell walls, membrane integrity and further changed the cell morphology with concentration increased. Conclusion: In our study, berberine has excellent anti-MRSA activities and has synergistic antibacterial property when combined with clindamycin and rifamycin separately, and the mechanism of activities involves the destruction of cell wall and membrane. Keywords: methicillin-resistant Staphylococcus aureus , berberine, multi-locus sequence types, synergistic effects, biofilm, mechanism Staphylococcus aureus ( S. aureus ), a major pathogen of healthcare-associated infections, causes many infectious diseases in hospital and community (eg, pneumonia, endocarditis, and bacteremia). 1 Due to its well-known exotoxins and ability to form biofilms, 2 the S. aureus infections are particularly difficult to treat. Furthermore, S. aureus rapidly develops resistance to the β-lactams antibiotics via the acquisition of the staphylococcal chromosome cassette carrying mecA gene. 3–5 The Methicillin-resistance S. aureus (MRSA) has become one of the most lethal pathogen in bacteremia. The case fatality rate of MRSA bacteremia has been reported to be up to 27.3%, with a mortality rate approximately 2–3 times higher than those infected with methicillin-susceptible S. aureus . 6 Although vancomycin remains the most effective antibiotic currently, the treatment of MRSA infections is still challenging due to the dramatic increase in MRSA isolation and the limited clinical treatment options. 7,8 Thus, there is a strong need to develop novel antibiotics for the treatment of MRSA. Berberine (BER) is an isoquinoline quaternary alkaloid (5,6-dihydrodibenzo quinolizinium derivative) isolated from many medicinal plants, such as Hydrastis canadensis, Berberis aristata, Coptis chinensis, Coptis rhizome, Coptis japonica, Phellodendron amurense , and Phellodendron chinense schneid . 9 BER is used to treat diarrhea and bowel disorders in China, with the potential to be used for the treatment of many diseases. 10 Furthermore, BER has received extensive attention for its role as an antimicrobial, 11–13 antifungal, 14 anti-tumor, 15 -Abstract Truncated-
pharmacology & pharmacy,infectious diseases